Naseer Muhammad Saad, Chand Raj, Coppola Stefano, Abreo Adrian, Sharma Mukesh, Singh Neeraj
John C. McDonald Regional Transplant Center - Willis Knighton Health System.
Department of Internal Medicine, Division of Nephrology, Louisiana State University Health Sciences Center (LSUHSC), Shreveport, LA, and.
Clin Nephrol Case Stud. 2020 May 29;8:46-48. doi: 10.5414/CNCS110131. eCollection 2020.
Renal phospholipidosis is a rare cause of proteinuria and kidney dysfunction. We describe a kidney transplant recipient who presented with slowly rising serum creatinine, nephrotic range proteinuria, and lower extremity edema 10 years post transplant. He was diagnosed with renal phospholipidosis on the transplant kidney biopsy. Patient did not have prior history or current symptoms or signs of Fabry disease. Serum α-galactosidase level was normal. The etiology was suspected to be due to chronic use of sertraline, a previously reported cause of drug-induced renal phospholipidosis. Sertraline was discontinued, and proteinuria declined with stabilization of kidney function at 6-months follow-up.
肾磷脂沉积症是蛋白尿和肾功能不全的罕见病因。我们描述了一名肾移植受者,他在移植后10年出现血清肌酐缓慢升高、肾病范围蛋白尿和下肢水肿。移植肾活检诊断为肾磷脂沉积症。患者既往无法布里病病史,目前也没有相关症状或体征。血清α-半乳糖苷酶水平正常。病因怀疑是长期使用舍曲林,此前有报道称该药可导致药物性肾磷脂沉积症。停用舍曲林后,蛋白尿减少,肾功能在6个月的随访中保持稳定。